Navigation Links
Beijing Chaoyang District Court Grants Investigation Letters Against Inverness Medical Beijing, A Subsidiary of Alere Inc.
Date:4/11/2011

BEIJING, April 11, 2011 /PRNewswire-Asia/ -- Chinmax Medical Systems Inc., a leading cardiac biomarker distributor in China announced an update regarding the progress of its lawsuit against Inverness Medical Beijing (IMB), a subsidiary of Alere Inc.(NYSE: ALR).

According to the Complaint, Inverness Medical Beijing secretly imported massive quantities of Triage product and sold the same to Chinmax customers during the period when Chinmax retained the undisputed contractual rights as Alere's exclusive distributor of Triage product for the China market. The Complaint also alleges that IMB violated Chinmax's proprietary rights under the distribution agreement by submitting applications to the State Food and Drug Administration (SFDA) and attempting to change Chinmax's legal status on the SFDA registrations of the Triage products. Chinmax filed suit in Beijing Chaoyang District Court in March 2010, claiming tort damages for unfair competition against Inverness Medical Beijing. Chinmax applied to the court for investigation letters allowing the collection of evidence regarding IMB's sales invoices, importation documents, and SFDA submissions. In recent progress, the Beijing Chaoyang District Court approved Chinmax's application and has now sent investigation letters to China Customs, State Taxation Office, and the SFDA, seeking the relevant documentation. The court is currently in the process of collecting this evidence from the China authorities. Chinmax believes the evidence will support both the China litigation against IMB and the U.S. arbitration Chinmax has filed against Alere San Diego for fraud, breach of contract and unfair competition due to unfair and illegal conduct.

Since 1999, Chinmax has been the exclusive distributor in China of diagnostics products manufactured by Biosite Incorporated (now known as “Alere San Diego”), a world-leading cardiac biomarkers company in San Diego, California, USA. In 2007, Biosite was acquired by Inverness Medical Innovations, Inc. (now known as Alere, Inc. (NYSE: ALR)).  Inverness Medical Beijing, a Chinese subsidiary of Alere, Inc., said the company obtained the right to manage contracts between Biosite and Chinmax in December 2008.


'/>"/>
SOURCE Chinmax Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Tianyins Dr. James Jiayuan Tong is Invited to Speak at the CFO China Summit 2011 on January 19, 2011 at the St. Regis Hotel, Beijing
2. Rodobo International, Inc. to Present at Rodman & Renshaw Conference in Beijing on March 8, 2010
3. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
4. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
5. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
6. WuXi PharmaTech (NYSE: WX) Holds Its Third Life Science and Chemistry Awards Ceremony in Beijing
7. For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
8. For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
9. China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit
10. China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit
11. CSOFT Announces Introduction of L10NPRO 3.0 at 6th Annual Worldwide Summit in Beijing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced ... for two key immunotherapy technologies from the University ... provides a method to monitor a patient for ... PD-L1 and CTLA-4.  The second license extends the ... patient is likely to have an immune-related adverse ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
(Date:2/23/2017)... Aviva Systems Biology Corporation (ASB) which ... GenWay Biotech Incorporated, a protein solutions and applications ... for both the research and diagnostic markets. ... capabilities for both entities. GenWay,s 18 years of experience ... complement ASB,s objective to become a leading provider ...
Breaking Biology Technology:
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
(Date:1/24/2017)... YORK , Jan. 24, 2017 ... study of the laboratory use of nuclear magnetic ... 363 experienced end-users and profiled current practices, developments, ... years, as well as growth and opportunities. These ... Instrument suppliers, NMR instruments, needs and innovation requirements, ...
(Date:1/21/2017)... Jan 20, 2017 Research and Markets has ... 2017-2021" report to their offering. ... The global voice recognition biometrics market to ... The report covers the present scenario and the growth ... calculate the market size, the report considers the revenue generated from ...
Breaking Biology News(10 mins):